Usefulness of Consecutive Fecal Calprotectin Measurements to Predict Relapse in Inflammatory Bowel Disease Patients Under Maintenance Treatment With Anti-TNF Therapy: A Prospective Longitudinal Cohort Study

被引：0
|
作者：
Ferreiro, Rocio
Barreiro-de Acosta, M.
Lorenzo-Gonzalez, Aurelio
Dominguez-Munoz, Enrique
机构：
来源：
GASTROENTEROLOGY | 2016年 / 150卷 / 04期
关键词：
D O I：
10.1016/S0016-5085(16)31459-7
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Sa1971
引用
下载
收藏
页码：S420 / S420
页数：1
相关论文
共 50 条
  • [31] ANTI-TNF THERAPY INDUCED ARTHRITIS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    Reilly, Elizabeth
    Edwards, Cathryn
    Mackay, Kirsten
    RHEUMATOLOGY, 2015, 54 : 94 - 94
  • [32] Microreinduction of injectable anti-TNF therapy in Patients with Inflammatory Bowel Disease
    Ligler, Robin
    Horst, Sara
    Duley, Caroline
    Wagnon, Julianne
    Beaulieu, Dawn
    Schwartz, David
    INFLAMMATORY BOWEL DISEASES, 2011, 17 : S41 - S42
  • [33] Ustekinumab and Anti-TNF Combination Therapy in Patients with Inflammatory Bowel Disease
    Yzet, Clara
    Dupas, Jean-Louis
    Fumery, Mathurin
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 (05): : 748 - 749
  • [34] Lipid Profile in Inflammatory Bowel Disease Patients on Anti-TNFα Therapy
    Miranda-Bautista, Jose
    de Gracia, Celia
    Lopez-Ibanez, Maria
    Barrientos, Maria
    Marin-Jimenez, Ignacio
    Diaz-Redondo, Alicia
    Menchen, Luis
    GASTROENTEROLOGY, 2014, 146 (05) : S577 - S577
  • [35] AN AUDIT OF ADHERENCE TO ANTI-TNF THERAPY IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    Duncan, J.
    Sastrillo, M.
    Baker, J.
    Younge, L.
    Anderson, S.
    Lindsay, J.
    Sanderson, J.
    Irving, P.
    GUT, 2011, 60
  • [36] Lipid Profile in Inflammatory Bowel Disease Patients on Anti-TNFα Therapy
    José Miranda-Bautista
    Celia de Gracia-Fernández
    María López-Ibáñez
    María Barrientos
    Alejandra Gallo-Moltó
    Marina González-Arias
    Casilda González-Gil
    Alicia Díaz-Redondo
    Ignacio Marín-Jiménez
    Luis Menchén
    Digestive Diseases and Sciences, 2015, 60 : 2130 - 2135
  • [37] Prospective study of prevalence and incidence of vertebral fractures in long-term anti-TNF alpha maintenance therapy treatment for inflammatory bowel disease
    Maldonado Perez, B.
    Vazquez Gamez, M. A.
    Castro Laria, L.
    Montoya Garcia, M. J.
    Perez Cano, R.
    Herrerias Gutierrez, J. M.
    JOURNAL OF CROHNS & COLITIS, 2014, 8 : S220 - S220
  • [38] Prospective Study of Prevalence an Incidence of Vertebral Fractures in Long-Term Anti-TNF Alpha Maintenance Therapy Treatment for Inflammatory Bowel Disease
    Maldonado-Perez, Belen
    Vazquez-Gamez, Maria Angeles
    Castro-Laria, Luisa
    Montoya-Garcia, Maria Jose
    Perez-Cano, Ramon
    Herrerias, Juan M.
    GASTROENTEROLOGY, 2014, 146 (05) : S246 - S246
  • [39] Infliximab but not adalimumab drug levels predict faecal calprotectin response in Inflammatory Bowel Disease patients on dose-intensified anti-TNF therapy
    Noack, S.
    Little, R.
    Vaz, K.
    Ward, M.
    Sparrow, M.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 : S471 - S472
  • [40] Anti-TNF Treatment for Extraintestinal Manifestations of Inflammatory Bowel Disease in the Swiss IBD Cohort Study
    Vavricka, Stephan R.
    Gubler, Martin
    Gantenbein, Claudine
    Spoerri, Muriel
    Froehlich, Florian
    Seibold, Frank
    Protic, Marijana
    Michetti, Pierre
    Straumann, Alex
    Fournier, Nicolas
    Juillerat, Pascal
    Biedermann, Luc
    Zeitz, Jonas
    Misselwitz, Benjamin
    Scharl, Michael
    Heinrich, Henriette
    Manser, Christine N.
    Safroneeva, Ekaterina
    Ali, Raja Affendi Raja
    Rogler, Gerhard
    Schoepfer, Alain M.
    Greuter, Thomas
    INFLAMMATORY BOWEL DISEASES, 2017, 23 (07) : 1174 - 1181
12345